2018
DOI: 10.1016/j.jcrc.2018.01.026
|View full text |Cite
|
Sign up to set email alerts
|

Thyrotoxicosis induced cardiomyopathy requiring support with extracorporeal membrane oxygenation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
6
1

Year Published

2020
2020
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 11 publications
(7 citation statements)
references
References 10 publications
0
6
1
Order By: Relevance
“…The use of ECMO had a trend towards increased mortality (2.86, CI 0.69-11.92), with a mortality of 72.2% among 13 of 18 patients, as compared to 9.3% in patients not requiring ECMO ( 39 ). These numbers, albeit small, suggest a significantly higher mortality in patients requiring use of extra-corporeal systems, and this differs from the established mortality rate of 10-30%, and vary significantly from the numbers in our review and White et al.’s review in patients requiring ECMO ( 21 ). Similarly Muller et al.…”
Section: Discussioncontrasting
confidence: 91%
See 1 more Smart Citation
“…The use of ECMO had a trend towards increased mortality (2.86, CI 0.69-11.92), with a mortality of 72.2% among 13 of 18 patients, as compared to 9.3% in patients not requiring ECMO ( 39 ). These numbers, albeit small, suggest a significantly higher mortality in patients requiring use of extra-corporeal systems, and this differs from the established mortality rate of 10-30%, and vary significantly from the numbers in our review and White et al.’s review in patients requiring ECMO ( 21 ). Similarly Muller et al.…”
Section: Discussioncontrasting
confidence: 91%
“…Three patients survived, with normalization of thyroid function and improved cardiovascular function. A subsequent review by White et al (21) published in 2018 reported the successful use of ECMO with survival in 11 out of 14 patients (22)(23)(24) between 1970 to 2017 with thyrotoxicosis-induced cardiomyopathy, with near complete recovery of left ventricular function. A review of the cases with the use of ECMO and other extra-corporeal systems in patients with severe thyrotoxicosis or thyroid storm has been summarized in Table 1, including additional new cases reported from 2018 to 2021 (25)(26)(27)(28) and conference poster reports (29)(30)(31)(32).…”
Section: Evidence Of Use Of Extra-corporeal Systems In Tsmentioning
confidence: 99%
“…White et al . performed a systematic review in which there were a 78.5% survival rate and near complete recovery of left ventricular function; these patients were managed with VA-ECMO [ 31 ]. The main drawback observed by the researchers was elevated after load on the left ventricle.…”
Section: Discussionmentioning
confidence: 99%
“…Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) helps maintain sufficient end-organ perfusion and is an efficacious treatment for patients with severe cardiogenic shock from causes including post-cardiac surgery, acute myocardial infarction, myocarditis, and post-cardiac arrest [ 7 9 ]. The role of ECMO in circulatory collapse resulting from endocrine emergencies remains unclear [ 10 ].…”
Section: Discussionmentioning
confidence: 99%